speb/financial-data huggingface dataset:
Stock screener scorecard for XPER (quarterly, report date 2026-03-31)
Altman Z-score: -0.48467506482181466 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0.9497527375485694%
Earnings yield: 0.5931470912132828%
Capitalized R&D asset: 60942920
ROCI (R&D adjusted): -0.30509792262214463%
Rosenberg metric: 0.03466577278694936
Free cash flow margin: -26.868115510568625%
Revenue growth: -1.9749886272927806%
Rule of 40 score: -28.843104137861406
Market cap: 365414944 (Small Cap ($300M-$2B))
Debt to equity: 0.16579999999999998
Free cash flow (dilution adjusted): -30685000
Operating income: 2151000
Net income: -7826000
Long score: 2 | Short score: 11
Recommendation: Short
Stock screener scorecard for 1161.HK (annual, report date 2025-09-30)
Altman Z-score: 1.631076186090431 (Distress Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 120.8333333333333%
Earnings yield: 24.829523451718778%
Return on net tangible assets: 78.43669679922701%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 41.70949933371406%
Free cash flow margin: 39.577554634813424%
Revenue growth: -0.3195999609224896%
Rule of 40 score: 39.257954673890936
Market cap: 585275377.0400001 (Small Cap ($300M-$2B))
P/E ratio: 7.202680068916292
Debt to equity: 0.4810251424986504
Free cash flow (dilution adjusted): 49921336.76092545
Operating income: 24500899.74293059
Net income: 10444473.007712081
Long score: 12 | Short score: 2
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for 3063.T (annual, report date 2026-02-28)
Altman Z-score: 2.2618845559856826 (Grey Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 5.7976966256109925%
Earnings yield: 0.014105087244150325%
Return on net tangible assets: 30.956842059510205%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.780790506238071%
Free cash flow margin: 10.129384552223089%
Revenue growth: 16.884384181208354%
Rule of 40 score: 27.01376873343144
Market cap: 10079635292.999998 (Large Cap ($10B-$200B))
P/E ratio: 32.29420603359616
Debt to equity: 3.6876926413546367
Free cash flow (dilution adjusted): 8478576.928012319
Operating income: 2697433.594251251
Net income: 2002559.9897343768
Long score: 6 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6159.T (annual, report date 2025-08-31)
Altman Z-score: 4.965290454527379 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 5.176432400487486%
Earnings yield: 0.26335589823471295%
Return on net tangible assets: 6.345337058026791%
Capitalized R&D asset: 1637235.0003274411
ROCI (R&D adjusted): 4.2277533574602515%
Rosenberg metric: 2.449187100830178
Free cash flow margin: 26.791600402049543%
Revenue growth: 21.460415199745476%
Rule of 40 score: 48.25201560179502
Market cap: 7709199289.999999 (Mid Cap ($2B-$10B))
P/E ratio: 9.84652550144584
Debt to equity: 0.024153985213184043
Free cash flow (dilution adjusted): 10553784.317732817
Operating income: 4289120.512296478
Net income: 5333714.83071054
Long score: 8 | Short score: 0
Recommendation: Long
Stock screener scorecard for 6627.T (annual, report date 2025-12-31)
Altman Z-score: 1.9767590498607621 (Grey Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 10.48342325604816%
Earnings yield: 0.04798606973119445%
Return on net tangible assets: -21.404259330341453%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.40515459328328%
Free cash flow margin: -23.321742467771877%
Revenue growth: 12.9147642085921%
Rule of 40 score: -10.406978259179777
Market cap: 57457972641.41402 (Large Cap ($10B-$200B))
P/E ratio: 8.263954889441472
Debt to equity: 0.4847453607652041
Free cash flow (dilution adjusted): -62246550.73205038
Operating income: 56863052.23451186
Net income: 44452669.26667093
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AKZA.AS (annual, report date 2025-12-31)
Altman Z-score: 1.8657861670116664 (Grey Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 27.800334368282776%
Earnings yield: 10.508691166877995%
Return on net tangible assets: 85.94657375145181%
Capitalized R&D asset: 627936274.509804
ROCI (R&D adjusted): 11.424599601902358%
Rosenberg metric: 0.7972575516693134
Free cash flow margin: 5.9657412876550495%
Revenue growth: 7.110117690993864%
Rule of 40 score: 13.075858978648913
Market cap: 9842898000.000002 (Mid Cap ($2B-$10B))
P/E ratio: 14.668998509687034
Debt to equity: 1.0082953131480712
Free cash flow (dilution adjusted): 712941176.4705882
Operating income: 1369411764.7058823
Net income: 789411764.7058824
Long score: 11 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for ATR (annual, report date 2025-12-31)
Altman Z-score: 3.734425474404552 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 20.689103570047322%
Earnings yield: 5.267164185023389%
Return on net tangible assets: 50.687375970046276%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.502217790041051%
Free cash flow margin: 6.63508050051083%
Revenue growth: 5.422745325700761%
Rule of 40 score: 12.057825826211591
Market cap: 7722896439.160001 (Mid Cap ($2B-$10B))
P/E ratio: 19.66169225502751
Debt to equity: 0.5644457963480168
Free cash flow (dilution adjusted): 250619000
Operating income: 510875000
Net income: 392789000
Long score: 10 | Short score: 0
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for CAMT (annual, report date 2025-12-31)
Altman Z-score: 16.63879915452375 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 15.00016965473506%
Earnings yield: 0.608767551200298%
Return on net tangible assets: 9.032174481220288%
Capitalized R&D asset: 25099667.000909623
ROCI (R&D adjusted): 11.369601326191392%
Rosenberg metric: 2.0205954432535598
Free cash flow margin: 22.210485574674642%
Revenue growth: 32.6527762502651%
Rule of 40 score: 54.86326182493974
Market cap: 15778908806.553 (Large Cap ($10B-$200B))
P/E ratio: 311.0860929488782
Debt to equity: 0.8602762061124501
Free cash flow (dilution adjusted): 34647798.74213836
Operating income: 40315408.80503144
Net income: 15950314.465408804
Long score: 11 | Short score: 1
Recommendation: Long
Stock screener scorecard for EXE (annual, report date 2025-12-31)
Altman Z-score: 2.6067876278862925 (Grey Zone)
Piotroski F-score: 9 (Strong)
Return on capital: 11.389231401561858%
Earnings yield: 11.203553133412328%
Return on net tangible assets: 25.158789966627193%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.915465217048768%
Free cash flow margin: 13.110181311018131%
Revenue growth: 188.77043354655294%
Rule of 40 score: 201.88061485757106
Market cap: 26099867425.899998 (Large Cap ($10B-$200B))
P/E ratio: 14.348470272622318
Debt to equity: 0.27236516309613523
Free cash flow (dilution adjusted): 1598000000
Operating income: 2771000000
Net income: 1819000000
Long score: 12 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for JST.DE (annual, report date 2025-12-31)
Altman Z-score: 1.8079491038513362 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 18.093872819022785%
Earnings yield: 6.496848818457542%
Capitalized R&D asset: 62671710.29411765
ROCI (R&D adjusted): 7.908947004274299%
Rosenberg metric: 8.422084045750452
Free cash flow margin: 8.236278735070277%
Revenue growth: 62.028237934410704%
Rule of 40 score: 70.26451666948098
Market cap: 862277900.0000001 (Small Cap ($300M-$2B))
Debt to equity: 1.8917991522143902
Free cash flow (dilution adjusted): 148658823.52941176
Operating income: 88501176.47058824
Net income: -15852941.176470589
Long score: 4 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for LXFR (annual, report date 2025-12-31)
Altman Z-score: 3.456103893622399 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 26.022304832713754%
Earnings yield: 6.8611961359248905%
Return on net tangible assets: 14.050719671007538%
Capitalized R&D asset: 8766000
ROCI (R&D adjusted): 12.440562418083772%
Rosenberg metric: 0.7954545454545454
Free cash flow margin: 5.876235049401976%
Revenue growth: -1.862720081653483%
Rule of 40 score: 4.013514967748494
Market cap: 358645111.52 (Small Cap ($300M-$2B))
P/E ratio: 46.57728721038961
Debt to equity: 0.22791519434628976
Free cash flow (dilution adjusted): 22600000
Operating income: 35000000
Net income: 7700000
Long score: 12 | Short score: 1
Recommendation: Strong Long (L/S Compounder)
Stock screener scorecard for PKG (annual, report date 2025-12-31)
Altman Z-score: 3.760482347395423 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 16.606479093085706%
Earnings yield: 4.764660754721146%
Return on net tangible assets: 22.794846382556987%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.928406656780359%
Free cash flow margin: 7.602371708586876%
Revenue growth: 7.2286569727911445%
Rule of 40 score: 14.83102868137802
Market cap: 18147612420.96 (Large Cap ($10B-$200B))
P/E ratio: 23.44349879984498
Debt to equity: 0.9493040452370596
Free cash flow (dilution adjusted): 683400000
Operating income: 1255400000
Net income: 774100000
Long score: 8 | Short score: 1
Recommendation: Long
Stock screener scorecard for RANI3.SA (annual, report date 2025-12-31)
Altman Z-score: 1.5262555960625115 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 16.98056802334305%
Earnings yield: 2.7335878416634842%
Return on net tangible assets: 21.1583921655341%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 12.939167003526657%
Free cash flow margin: 14.834392944124778%
Revenue growth: 22.269622950843196%
Rule of 40 score: 37.10401589496797
Market cap: 1895853904.093932 (Small Cap ($300M-$2B))
P/E ratio: 7.832488758909035
Debt to equity: 1.3512439270655556
Free cash flow (dilution adjusted): 45648540.145985395
Operating income: 81366605.83941606
Net income: 44169708.029197074
Long score: 6 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for UWS.DE (annual, report date 2025-12-31)
Altman Z-score: 2.872197842225391 (Grey Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 23.31005869257235%
Earnings yield: 4.319197618322933%
Return on net tangible assets: -30.625571372600234%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 11.428642306070303%
Free cash flow margin: 10.50230122202825%
Revenue growth: 14.23650455513756%
Rule of 40 score: 24.73880577716581
Market cap: 88436429431.62354 (Large Cap ($10B-$200B))
P/E ratio: 32.64541507258159
Debt to equity: 2.2927634871384246
Free cash flow (dilution adjusted): 2647000000
Operating income: 4607000000
Net income: 2709000000
Long score: 7 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 3673.T (annual, report date 2025-12-31)
Altman Z-score: 3.1743753466156672 (Safe Zone)
Piotroski F-score: 8 (Strong)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -82.39975271539421%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 7.90888295800599%
Free cash flow margin: 10.516326427371867%
Revenue growth: 15.777908878054856%
Rule of 40 score: 26.294235305426724
Market cap: 66387551698.73066 (Large Cap ($10B-$200B))
P/E ratio: 53.526908925697875
Debt to equity: 0.18349265942176135
Free cash flow (dilution adjusted): 13995300.811968546
Operating income: 13187590.307525095
Net income: 7929576.114059203
Long score: 9 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 5532.T (annual, report date 2025-09-30)
Altman Z-score: 1.4489311719365632 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -206.05234258056714%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 6.007957586415721%
Free cash flow margin: -43.601510131027396%
Revenue growth: 18.368316442080353%
Rule of 40 score: -25.233193688947043
Market cap: 19942082250 (Large Cap ($10B-$200B))
P/E ratio: 35.6605311862952
Debt to equity: 4.1593695203524765
Free cash flow (dilution adjusted): -28731218.034993272
Operating income: 7020053.835800808
Net income: 3763257.065948856
Long score: 2 | Short score: 8
Recommendation: Short
Stock screener scorecard for 7681.T (annual, report date 2025-09-30)
Altman Z-score: 4.004036456009191 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.182203550479602%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.300932658688931%
Free cash flow margin: -0.7855268289525404%
Revenue growth: 4.259843450621384%
Rule of 40 score: 3.4743166216688435
Market cap: 6667905138 (Mid Cap ($2B-$10B))
P/E ratio: 38.83575606744518
Debt to equity: 0
Free cash flow (dilution adjusted): -1135975.7738896366
Operating income: 1940047.1063257067
Net income: 1155417.2274562584
Long score: 4 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for 7957.T (annual, report date 2025-12-31)
Altman Z-score: 1.1552187658187565 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -32.7233135422249%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.086074471979673%
Free cash flow margin: -5.608359658038016%
Revenue growth: -5.3104339201733755%
Rule of 40 score: -10.918793578211393
Market cap: 2261922724.7462344 (Mid Cap ($2B-$10B))
Debt to equity: 0.34157150035717165
Free cash flow (dilution adjusted): -3039063.9984655716
Operating income: -1471836.8390767854
Net income: -17269183.556038618
Long score: 2 | Short score: 9
Recommendation: Short
Stock screener scorecard for 8516.HK (annual, report date 2025-03-31)
Altman Z-score: -1.354132538695668 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -92.76910435497123%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 14.646053702196907%
Free cash flow margin: -14.231261555966434%
Revenue growth: 108.52791817414207%
Rule of 40 score: 94.29665661817563
Market cap: 55821948 (Micro Cap ($50M-$300M))
Debt to equity: 0.21843330594357707
Free cash flow (dilution adjusted): -643059.1259640103
Operating income: 138817.48071979434
Net income: -932005.1413881747
Long score: 2 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AGX.V (annual, report date 2025-12-31)
Altman Z-score: 3.173160697732839 (Safe Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -32.72536892577733%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -5.796176259389183%
Free cash flow margin: -35.934318277821234%
Revenue growth: 20.529999477612158%
Rule of 40 score: -15.404318800209076
Market cap: 309018126.6 (Small Cap ($300M-$2B))
Debt to equity: 0.07976327337725536
Free cash flow (dilution adjusted): -6619243.065693431
Operating income: -1972702.1897810218
Net income: -3474261.313868613
Long score: 5 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AVG.L (annual, report date 2025-05-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1499401.5232 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for BKY.L (annual, report date 2025-06-30)
Altman Z-score: -0.6590023392061942 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -6.6770720676433%
Capitalized R&D asset: 55072.8476821192
ROCI (R&D adjusted): -4.258341787783467%
Free cash flow margin: -152.44708994708998%
Revenue growth: -16.392953120334433%
Rule of 40 score: -168.8400430674244
Market cap: 2712606.404782192 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -3013071.895424837
Operating income: -2232026.1437908495
Net income: -3550980.3921568627
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for DFSC (annual, report date 2025-09-30)
Altman Z-score: -5.494683040730494 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -160.49931915895388%
Capitalized R&D asset: 3245849.7918465226
ROCI (R&D adjusted): -60.86614882098461%
Rosenberg metric: 0.5103859679103491
Free cash flow margin: -166.67722785418118%
Revenue growth: 219.1054183843804%
Rule of 40 score: 52.42819053019923
Market cap: 13195561.7888 (Nano Cap (< $50M))
Debt to equity: 0.16707215422652366
Free cash flow (dilution adjusted): -5926785.611510792
Operating income: -6532698.56115108
Net income: -6925679.136690648
Long score: 3 | Short score: 9
Recommendation: Short
Stock screener scorecard for EDD (annual, report date 2025-10-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 18.653961596862125%
Capitalized R&D asset: 0
Free cash flow margin: 35.40683499907327%
Revenue growth: 81.76847124679296%
Rule of 40 score: 117.17530624586622
Market cap: 315834630.3 (Small Cap ($300M-$2B))
P/E ratio: 4.599042291114541
Debt to equity: 0.1629783754858793
Free cash flow (dilution adjusted): 24834000
Net income: 68674000
Long score: 5 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for FOBI.V (annual, report date 2025-06-30)
Altman Z-score: -81.08821504481178 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 220156.91608583502
Free cash flow margin: -169.05826151194287%
Revenue growth: -62.04005937491821%
Rule of 40 score: -231.09832088686107
Market cap: 9787279.08 (Nano Cap (< $50M))
Debt to equity: -0.009582253379740481
Free cash flow (dilution adjusted): -626410.2189781021
Operating income: -2152002.919708029
Net income: -809731.3868613138
Long score: 1 | Short score: 13
Recommendation: Short
Stock screener scorecard for FRT (annual, report date 2025-12-31)
Altman Z-score: 1.0200373937055751 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 15.395303581613867%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 5.233965894415613%
Free cash flow margin: 24.741062178697785%
Revenue growth: 6.3639130709583425%
Rule of 40 score: 31.10497524965613
Market cap: 8441088438.87 (Mid Cap ($2B-$10B))
P/E ratio: 19.92476876763256
Debt to equity: 1.4363960771755802
Free cash flow (dilution adjusted): 316432000
Operating income: 459513000
Net income: 423648000
Long score: 3 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for FSV (annual, report date 2025-12-31)
Altman Z-score: 4.229387440003133 (Safe Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -30.641084190128236%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 10.295237806855258%
Free cash flow margin: 5.290568440200091%
Revenue growth: 9.993924035214508%
Rule of 40 score: 15.284492475414599
Market cap: 9754777696.4645 (Mid Cap ($2B-$10B))
P/E ratio: 51.13987478945672
Debt to equity: 0.7434160853618589
Free cash flow (dilution adjusted): 212298540.1459854
Operating income: 255619708.02919707
Net income: 139231386.86131385
Long score: 7 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for GCTK (annual, report date 2025-12-31)
Altman Z-score: -30.41203054268488 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -687.4823196605374%
Capitalized R&D asset: 17729650
ROCI (R&D adjusted): -68.68273009323713%
Rule of 40 score: 0
Market cap: 25384409.73 (Nano Cap (< $50M))
Debt to equity: 1.2185289957567185
Free cash flow (dilution adjusted): -15547000
Operating income: -16090000
Net income: -19388000
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for GNL (annual, report date 2025-12-31)
Altman Z-score: -0.21295393996343256 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -1.7399233432245302%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.764092075377797%
Free cash flow margin: 35.714718364742794%
Revenue growth: -13.0761522166822%
Rule of 40 score: 22.638566148060594
Market cap: 1741492574.25 (Small Cap ($300M-$2B))
Debt to equity: 1.5484647411659047
Free cash flow (dilution adjusted): 176890000
Operating income: 187624000
Net income: -225457000
Long score: 3 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for GUN.V (annual, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 36459659.129999995 (Nano Cap (< $50M))
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ISGI.V (annual, report date 2025-06-30)
Altman Z-score: -35.56527944725424 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Free cash flow margin: -29.492834419981733%
Revenue growth: 13.430282659304005%
Rule of 40 score: -16.062551760677728
Market cap: 2489544.8467153283 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -234092
Operating income: -397243
Net income: -400216
Long score: 2 | Short score: 9
Recommendation: Neutral
Stock screener scorecard for KDA.V (annual, report date 2025-07-31)
Altman Z-score: 11.389963360651578 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -380.0122523247415%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -95.765800238798%
Free cash flow margin: -4138.44367998162%
Revenue growth: 12.200763819640876%
Rule of 40 score: -4126.242916161979
Market cap: 61112812.80000001 (Micro Cap ($50M-$300M))
Debt to equity: 0.08052370874136706
Free cash flow (dilution adjusted): -4960224.63768116
Operating income: -6481618.115942029
Net income: -5832612.31884058
Long score: 4 | Short score: 13
Recommendation: Short
Stock screener scorecard for MOLN.SW (annual, report date 2025-12-31)
Altman Z-score: -1.5632891874220598 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -74.96514464970372%
Capitalized R&D asset: 106226601.64757887
ROCI (R&D adjusted): -33.23136824258445%
Revenue growth: -100%
Rule of 40 score: -100
Market cap: 126787730.94 (Micro Cap ($50M-$300M))
Debt to equity: 0.04536061941394677
Free cash flow (dilution adjusted): -71379746.83544303
Operating income: -70172151.89873417
Net income: -78039240.5063291
Long score: 2 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for OBDC (annual, report date 2025-12-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.481591677155883%
Capitalized R&D asset: 0
Free cash flow margin: 245.40236930694883%
Revenue growth: 6.595418700713481%
Rule of 40 score: 251.9977880076623
Market cap: 5791884298.08 (Mid Cap ($2B-$10B))
P/E ratio: 9.23146266790138
Debt to equity: 1.2572293136435708
Free cash flow (dilution adjusted): 1741520000
Net income: 627407000
Long score: 2 | Short score: 1
Recommendation: Neutral
Stock screener scorecard for PTGX (annual, report date 2025-12-31)
Altman Z-score: 62.273691242138995 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -21.222956628117135%
Capitalized R&D asset: 291488890
ROCI (R&D adjusted): -15.097854012272476%
Free cash flow margin: 21.964099443671767%
Revenue growth: -17.200794595414877%
Rule of 40 score: 4.76330484825689
Market cap: 5616955317.820001 (Mid Cap ($2B-$10B))
Debt to equity: 0.01679336659579279
Free cash flow (dilution adjusted): 10107000
Operating income: -158127000
Net income: -130149000
Long score: 6 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for SAGA.V (annual, report date 2025-07-31)
Altman Z-score: 13.25086520117581 (Safe Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -48.30224759357517%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -54.24091973816182%
Rule of 40 score: 0
Market cap: 23238232.15 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -4173224.6376811597
Operating income: -2231382.6086956523
Net income: -1755065.2173913044
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for SKIN (annual, report date 2025-12-31)
Altman Z-score: -0.44281320157143256 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 13179980
ROCI (R&D adjusted): -6.892087545581226%
Rosenberg metric: 2.2344345616264296
Free cash flow margin: 5.817347651185212%
Revenue growth: -10.022315686192393%
Rule of 40 score: -4.20496803500718
Market cap: 180144055.6 (Micro Cap ($50M-$300M))
Debt to equity: 6.203419811320755
Free cash flow (dilution adjusted): 17498000
Operating income: -20803000
Net income: -9519000
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for SVRN (annual, report date 2024-12-31)
Altman Z-score: 122.88232226087047 (Safe Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -22.52222353917269%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -6.123029512860021%
Free cash flow margin: -98.09353357715354%
Revenue growth: 27.106741573033723%
Rule of 40 score: -70.98679200411982
Market cap: 1044454348.8 (Small Cap ($300M-$2B))
Debt to equity: 0
Free cash flow (dilution adjusted): -26262500.000000004
Operating income: -5381250
Net income: -18606250
Long score: 4 | Short score: 8
Recommendation: Short
Stock screener scorecard for TSBK (annual, report date 2025-09-30)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.143004987885405%
Capitalized R&D asset: 0
Free cash flow margin: 35.561620077535196%
Revenue growth: 10.616448018056143%
Rule of 40 score: 46.17806809559134
Market cap: 254643311.09 (Micro Cap ($50M-$300M))
P/E ratio: 8.732324374678509
Debt to equity: 0.08787421843466076
Free cash flow (dilution adjusted): 27886000
Net income: 29161000
Long score: 6 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for UWMC (annual, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -5.819969934934739%
Capitalized R&D asset: 0
Free cash flow margin: -178.4564753022915%
Revenue growth: 9.766002898728926%
Rule of 40 score: -168.69047240356258
Market cap: 1380647866.4 (Small Cap ($300M-$2B))
P/E ratio: 5.657859572253436
Debt to equity: 2.7569377816292246
Free cash flow (dilution adjusted): -2771968000
Net income: 244023000
Long score: 0 | Short score: 8
Recommendation: Short
Stock screener scorecard for 0052.HK (annual, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 577805440 (Small Cap ($300M-$2B))
P/E ratio: 1.6262755102040816
Debt to equity: 1.4221000000000001
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 0546.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 12634212352 (Large Cap ($10B-$200B))
P/E ratio: 0.8738104902358725
Debt to equity: 0.9068999999999999
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1723.HK (quarterly, report date 2025-09-30)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 310876800 (Small Cap ($300M-$2B))
Debt to equity: 0.2724
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1733.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 1788754688 (Small Cap ($300M-$2B))
P/E ratio: 0.9854327335047129
Debt to equity: 0.3566
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 1757.HK (annual, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 6960000000 (Mid Cap ($2B-$10B))
P/E ratio: 232.78061224489795
Debt to equity: 0.3071
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 212A.T (quarterly, report date 2026-04-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 44406677504 (Large Cap ($10B-$200B))
P/E ratio: 0.13196091212739275
Debt to equity: 0.0632
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3059.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3455858944 (Mid Cap ($2B-$10B))
Debt to equity: 1.0807
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3059.T (annual, report date 2026-03-31)
Altman Z-score: 1.96936054235421 (Grey Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -3.6831906418135643%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -2.9056647863902203%
Free cash flow margin: -1.3290923071323197%
Revenue growth: -14.080319741870156%
Rule of 40 score: -15.409412049002476
Market cap: 3455858944 (Mid Cap ($2B-$10B))
Debt to equity: 1.0807
Free cash flow (dilution adjusted): -989157.9079079079
Operating income: -2005505.5055055055
Net income: -2669488.2382382383
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for 3107.T (quarterly, report date 2026-03-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 303174778880 (Mega Cap (>= $200B))
P/E ratio: 0.05295762220836097
Debt to equity: 0.1082
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 3221.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 33125136384 (Large Cap ($10B-$200B))
P/E ratio: 0.10746748775631472
Debt to equity: 0.061
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3319.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2510816768 (Mid Cap ($2B-$10B))
P/E ratio: 3.550771208226221
Debt to equity: 0.036000000000000004
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3319.HK (annual, report date 2025-12-31)
Altman Z-score: 1.360127239077213 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 8.788098523247784%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.077682292120539%
Free cash flow margin: 5.465020225015416%
Revenue growth: -3.5677980787657217%
Rule of 40 score: 1.8972221462496943
Market cap: 2510816768 (Mid Cap ($2B-$10B))
P/E ratio: 3.550771208226221
Debt to equity: 0.036000000000000004
Free cash flow (dilution adjusted): 100653571.42857143
Operating income: 150301857.14285713
Net income: 30941285.714285713
Long score: 5 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 3IINFOLTD.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.115834266849911 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.206647197886246%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -3.476797307044963%
Revenue growth: -2.852650865870052%
Rule of 40 score: -2.852650865870052
Market cap: 4094150144 (Mid Cap ($2B-$10B))
P/E ratio: 0.07976830091200211
Debt to equity: 0.163
Operating income: -1532428.995337007
Net income: 770453.5820262823
Long score: 2 | Short score: 12
Recommendation: Short
Stock screener scorecard for 3IINFOLTD.NS (annual, report date 2026-03-31)
Altman Z-score: 1.9854372388963644 (Grey Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 18.749130858016965%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 0.7670113007934601%
Free cash flow margin: -6.76704742125303%
Revenue growth: -13.394181856718943%
Rule of 40 score: -20.161229277971973
Market cap: 4094150144 (Mid Cap ($2B-$10B))
P/E ratio: 0.07976830091200211
Debt to equity: 0.163
Free cash flow (dilution adjusted): -4972445.951674438
Operating income: 338066.9775328529
Net income: 3757948.283170835
Long score: 4 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for 4350.T (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 14321952768 (Large Cap ($10B-$200B))
P/E ratio: 0.09217949190664061
Debt to equity: 2.1634
Long score: 0 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for 4612.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 2598953287680 (Mega Cap (>= $200B))
P/E ratio: 0.11316278003171205
Debt to equity: 0.7393000000000001
Long score: 1 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 6662.T (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 3209777152 (Mid Cap ($2B-$10B))
Debt to equity: 0
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6676.HK (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 516789.04109589045
Rule of 40 score: 0
Market cap: 706617088 (Small Cap ($300M-$2B))
Debt to equity: 1.389
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 6676.HK (annual, report date 2025-12-31)
Altman Z-score: -0.7446186407070365 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -157.46125272191625%
Capitalized R&D asset: 13425097.891121075
ROCI (R&D adjusted): -37.510712540563404%
Rosenberg metric: -0.6414864908994288
Free cash flow margin: 24.070108880716052%
Revenue growth: 42.560334285657184%
Rule of 40 score: 66.63044316637324
Market cap: 706617088 (Small Cap ($300M-$2B))
Debt to equity: 1.389
Free cash flow (dilution adjusted): 72908428.57142858
Operating income: -42960142.85714286
Net income: -84526714.28571428
Long score: 4 | Short score: 11
Recommendation: Short
Stock screener scorecard for 6723.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 7126549790720 (Mega Cap (>= $200B))
Debt to equity: 0.4732
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 7823.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 27857319936 (Large Cap ($10B-$200B))
P/E ratio: 0.08920372350736654
Debt to equity: 0
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for 8060.HK (quarterly, report date 2026-03-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 31006170 (Nano Cap (< $50M))
P/E ratio: 1.1479591836734695
Debt to equity: 0.1344
Long score: 2 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 8060.HK (annual, report date 2026-03-31)
Altman Z-score: 0.23638941128832713 (Distress Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 3.995335013731612%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.704256817464366%
Free cash flow margin: -3.5494812821291926%
Revenue growth: 6.963287717985376%
Rule of 40 score: 3.4138064358561837
Market cap: 31006170 (Nano Cap (< $50M))
P/E ratio: 1.1479591836734695
Debt to equity: 0.1344
Free cash flow (dilution adjusted): -730102.0408163265
Operating income: -914413.2653061225
Net income: 336989.79591836734
Long score: 2 | Short score: 11
Recommendation: Short
Stock screener scorecard for 8713.T (annual, report date 2026-03-31)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 5.895964788816395%
Capitalized R&D asset: 0
Free cash flow margin: -92.7181432234985%
Revenue growth: -5.811342231727782%
Rule of 40 score: -98.52948545522628
Market cap: 38282063872 (Large Cap ($10B-$200B))
P/E ratio: 0.05073157612937295
Debt to equity: 1.2081708665541442
Free cash flow (dilution adjusted): -269169169.1691692
Net income: 25950950.95095095
Long score: 0 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for 8713.T (quarterly, report date 2026-03-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 38282063872 (Large Cap ($10B-$200B))
P/E ratio: 0.05073157612937295
Debt to equity: 1.2081708665541442
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for ADSE (quarterly, report date 2025-12-31)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 902308032 (Small Cap ($300M-$2B))
Debt to equity: -0.7575309554610976
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ADSE (annual, report date 2025-12-31)
Altman Z-score: -2.7437008599128725 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 17285292.769607842
ROCI (R&D adjusted): -279.5948043867773%
Rosenberg metric: -4.215495682165408
Free cash flow margin: -136.0055768560474%
Revenue growth: -67.60100544267229%
Rule of 40 score: -203.6065822987197
Market cap: 902308032 (Small Cap ($300M-$2B))
Debt to equity: -0.7575309554610976
Free cash flow (dilution adjusted): -50496470.5882353
Operating income: -65989411.76470588
Net income: -64929411.76470588
Long score: 1 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AFCONS.NS (quarterly, report date 2026-03-31)
Altman Z-score: 1.0283941586548178 (Distress Zone)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.6211997434055783%
Revenue growth: -16.43528591784729%
Rule of 40 score: -16.43528591784729
Market cap: 105168019456 (Large Cap ($10B-$200B))
P/E ratio: 0.42079052223574254
Debt to equity: 0.6654000000000001
Operating income: -6003603.221704112
Net income: -9368376.43069097
Long score: 1 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for AREC.L (quarterly, report date 2025-12-31)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 23975442 (Nano Cap (< $50M))
P/E ratio: 0.5472972972972974
Debt to equity: 0.0152
Long score: 2 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for AREC.L (annual, report date 2025-12-31)
Altman Z-score: 0.5456412942340643 (Distress Zone)
Piotroski F-score: 7 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 12.255358807082946%
Capitalized R&D asset: 8443491.964591173
ROCI (R&D adjusted): -38.25229176171653%
Rosenberg metric: 0.1478621008380956
Free cash flow margin: -162.54375729288216%
Revenue growth: 12.77985228076525%
Rule of 40 score: -149.7639050121169
Market cap: 23975442 (Nano Cap (< $50M))
P/E ratio: 0.5472972972972974
Debt to equity: 0.0152
Free cash flow (dilution adjusted): -3764864.8648648653
Operating income: -5466216.216216216
Net income: 897297.2972972973
Long score: 5 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for AUQ.AX (annual, report date 2024-06-30)
Altman Z-score: -0.9330279012578928 (Distress Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -8.839183370193778%
Free cash flow margin: -572.6481406124694%
Rule of 40 score: -572.6481406124694
Market cap: 31781010 (Nano Cap (< $50M))
Debt to equity: 9.0744
Free cash flow (dilution adjusted): -20855467.333333332
Operating income: -5815501.333333333
Net income: -3861750.6666666665
Long score: 0 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for AUST (quarterly, report date 2026-03-31)
Altman Z-score: 60.87845970441659 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -8.19933616963506%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -7.489181212838959%
Rule of 40 score: 0
Market cap: 13008351 (Nano Cap (< $50M))
Debt to equity: 0
Free cash flow (dilution adjusted): -421733.0935251799
Operating income: -415915.8273381295
Net income: -405520.86330935254
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for BCSS (quarterly, report date 2026-03-31)
Altman Z-score: 21.66531393416616 (Safe Zone)
Piotroski F-score: 2 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.8850059208151908%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.05488603677642596%
Rule of 40 score: 0
Market cap: 597140032 (Small Cap ($300M-$2B))
P/E ratio: 57.31575868776903
Debt to equity: 0
Free cash flow (dilution adjusted): -143262
Operating income: -257724
Net income: 4013166
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for CAPN (quarterly, report date 2026-03-31)
Altman Z-score: 9.644015032673769 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 0.7386547575073106%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.8111832553786679%
Rule of 40 score: 0
Market cap: 58697824 (Micro Cap ($50M-$300M))
P/E ratio: 57.89473684210526
Debt to equity: 0.03877644824473798
Free cash flow (dilution adjusted): 763
Operating income: -294218
Net income: 252400
Long score: 6 | Short score: 7
Recommendation: Neutral
Stock screener scorecard for CBR.V (quarterly, report date 2026-03-31)
Altman Z-score: 0.9950506998490867 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -10.573901037151206%
Rule of 40 score: 0
Market cap: 326794720 (Small Cap ($300M-$2B))
Debt to equity: -14.09606391065714
Free cash flow (dilution adjusted): -14637818.705035973
Operating income: -4501264.028776979
Net income: -5872594.244604317
Long score: 1 | Short score: 11
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CENTRUM.NS (quarterly, report date 2026-03-31)
Altman Z-score: 0.4993430134259996 (Distress Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 61.19473034710917%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 1.0213538798631252%
Revenue growth: 9.236380989537194%
Rule of 40 score: 9.236380989537194
Market cap: 11226846208 (Large Cap ($10B-$200B))
P/E ratio: 23.99578682195128
Debt to equity: 12.1868
Operating income: 23020125.052988555
Net income: 1439073.7600678254
Long score: 2 | Short score: 6
Recommendation: Neutral
Stock screener scorecard for CENTRUM.NS (annual, report date 2026-03-31)
Altman Z-score: 0.7371842097225582 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -181.4539791524445%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 4.462252289138214%
Free cash flow margin: -56.01597863711255%
Revenue growth: -1.7137218938227556%
Rule of 40 score: -57.72970053093531
Market cap: 11226846208 (Large Cap ($10B-$200B))
Debt to equity: 12.1868
Free cash flow (dilution adjusted): -219026198.60110217
Operating income: 100573961.42433235
Net income: -14650858.41458245
Long score: 0 | Short score: 10
Recommendation: Strong Short (Melting Ice Cube)
Stock screener scorecard for CYBE.V (quarterly, report date 2026-04-30)
Altman Z-score: -9.44758338308714 (Distress Zone)
Piotroski F-score: 4 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -599.6242679935374%
Free cash flow margin: -2740.026906245651%
Revenue growth: -8.832153833140666%
Rule of 40 score: -2748.8590600787916
Market cap: 47911620 (Nano Cap (< $50M))
Debt to equity: 1.0238
Free cash flow (dilution adjusted): -1771948
Operating income: -2234236
Net income: -2234233
Long score: 0 | Short score: 12
Recommendation: Short
Stock screener scorecard for EBQ.L (quarterly, report date 2025-12-31)
Piotroski F-score: 1 (Weak)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
Rule of 40 score: 0
Market cap: 13026815 (Nano Cap (< $50M))
Debt to equity: 1.0575
Long score: 0 | Short score: 2
Recommendation: Neutral
Stock screener scorecard for EBQ.L (annual, report date 2025-12-31)
Altman Z-score: 1.0798347362487344 (Distress Zone)
Piotroski F-score: 6 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Capitalized R&D asset: 0
ROCI (R&D adjusted): 9.408129016413573%
Free cash flow margin: 5.8313568332379155%
Revenue growth: 3.3170109299545043%
Rule of 40 score: 9.14836776319242
Market cap: 13026815 (Nano Cap (< $50M))
Debt to equity: 1.0575
Free cash flow (dilution adjusted): 5781081.081081081
Operating income: 6212162.162162162
Net income: -18964864.864864863
Long score: 3 | Short score: 3
Recommendation: Neutral
Stock screener scorecard for HERMA.OL (annual, report date 2025-12-31)
Altman Z-score: 155.57385191489357 (Safe Zone)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -11.964285714285715%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -4.7279214986619085%
Free cash flow margin: -408.3333333333333%
Revenue growth: -65.31190202831993%
Rule of 40 score: -473.64523536165325
Market cap: 206147760 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): -487562.18905472633
Operating income: -527363.1840796019
Net income: -1333333.3333333333
Long score: 4 | Short score: 9
Recommendation: Short
Stock screener scorecard for HERMA.OL (quarterly, report date 2025-12-31)
Altman Z-score: 155.6691533333333 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: -0.08928571428571429%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -1.6057091882247996%
Free cash flow margin: 25%
Revenue growth: 32.40464344941958%
Rule of 40 score: 57.40464344941958
Market cap: 206147760 (Micro Cap ($50M-$300M))
Debt to equity: 0
Free cash flow (dilution adjusted): 9950.248756218905
Operating income: -179104.4776119403
Net income: -9950.248756218905
Long score: 6 | Short score: 5
Recommendation: Neutral
Stock screener scorecard for IBN (annual, report date 2026-03-31)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 16.314936480915364%
Capitalized R&D asset: 0
Free cash flow margin: 28.032554751441463%
Revenue growth: -1.0699804577291143%
Rule of 40 score: 26.96257429371235
Market cap: 102316138496 (Large Cap ($10B-$200B))
P/E ratio: 16.289308176100626
Debt to equity: 0.546978389974366
Free cash flow (dilution adjusted): 6636999014.412887
Net income: 6139916002.54345
Long score: 4 | Short score: 0
Recommendation: Neutral
Stock screener scorecard for IBN (quarterly, report date 2026-06-30)
Piotroski F-score: 3 (Weak)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 4.399220216592448%
Capitalized R&D asset: 0
Revenue growth: 6.852824478968195%
Rule of 40 score: 6.852824478968195
Market cap: 105841704960 (Large Cap ($10B-$200B))
P/E ratio: 18.14375
Debt to equity: 0.568547305549248
Net income: 1717081970.6720116
Long score: 1 | Short score: 4
Recommendation: Neutral
Stock screener scorecard for ITH.TO (quarterly, report date 2026-03-31)
Altman Z-score: 930.7830999918846 (Safe Zone)
Piotroski F-score: 5 (Neutral)
Return on capital: 0%
Earnings yield: 0%
Return on net tangible assets: 1.3350946707822178%
Capitalized R&D asset: 0
ROCI (R&D adjusted): -0.6132765665327807%
Rule of 40 score: 0
Market cap: 753515968 (Small Cap ($300M-$2B))
P/E ratio: 92.61430163582502
Debt to equity: 0
Free cash flow (dilution adjusted): 1204542.4460431656
Operating income: -751531.654676259
Net income: 1636074.1007194247
Long score: 6 | Short score: 5
Recommendation: Neutral